News

CEPI, the Coalition for Epidemic Preparedness Innovations, and Dutch vaccine clinical development and manufacturing organization Intravacc, announced the latest funding award under…
Read More...

Intravacc announced that it has been awarded a contract with base and options that may total US$14.6 million from the US National Institute of Allergy and Infectious Diseases…
Read More...

BioLink Life Sciences of Cary, North Carolina, announced receiving a contract from BARDA (the Biomedical Advanced Research and Development Authority) to fund the development of…
Read More...

Pfizer Inc. announced the completion of its acquisition of Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company dedicated to the discovery, development and delivery of…
Read More...

Intravacc announced that it has been awarded a contract with base and options that may total US$14.6 million from the US National Institute of Allergy and Infectious Diseases (NIAID),…
Read More...

Myonex announced the completion of its acquisition of the clinical trial and packaging business of Hubertus Apotheke, located in Berlin, Germany. The new entity, Myonex GmbH, supports…
Read More...

Almac Clinical Services, a member of The Almac Group, the global contract development and manufacturing organisation, announces a new state-of-the-art Cryogenic Service Solution within…
Read More...

Personalis, Inc. has joined with Duke University and Olink Proteomics AB to form a research collaboration to study the effects of immunotherapy on advanced gastroesophageal cancer.…
Read More...

miRecule, Inc., an innovator of next-generation RNA therapeutics, announced a strategic collaboration and exclusive license agreement with Sanofi to develop and commercialize a…
Read More...

Japanese pharmaceutical company Shionogi & Co., Ltd. and the Medicines Patent Pool (MPP), a United Nations-backed public health organisation, reflecting a shared commitment to…
Read More...

Lineage Cell Therapeutics, Inc. a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, announced today the opening of a new research and…
Read More...

Pfizer Inc. announced the completion of its acquisition of Biohaven Pharmaceutical Holding Company Ltd., the maker of NURTEC ODT (rimegepant), an innovative migraine therapy approved…
Read More...

Biogen Inc. and Denali Therapeutics Inc. announced that dosing has commenced in the global Phase 3 LIGHTHOUSE study to evaluate the efficacy and safety profile of BIIB122 (DNL151), as…
Read More...

AmplifyBio, a contract research organization (CRO) focused on accelerating innovation across pharmaceutical modalities; announced the acquisition of select assets from PACT Pharma,…
Read More...

Alexion, AstraZeneca Rare Disease, announced that it has entered a definitive agreement to acquire Lexington, Mass.-based LogicBio Therapeutics, Inc., a pioneering genomic medicine…
Read More...

Vanda Pharmaceuticals Inc. (Vanda) and OliPass Corporation (OliPass) announced that they have entered into a research and development collaboration agreement to jointly develop a set of…
Read More...

InflaRx N.V. submitted a request for Emergency Use Authorization (EUA) following encouraging interactions with the US Food and Drug Administration (FDA) at a Type B meeting held this…
Read More...

Ventus Therapeutics, Inc., a biopharmaceutical company utilizing structural biology and a proprietary computational chemistry platform to identify and develop small molecule…
Read More...

Amylyx Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved RELYVRIO™ (sodium phenylbutyrate and taurursodiol) for the treatment of adults with…
Read More...

Myovant Sciences Ltd. confirmed that it has received a preliminary, non-binding proposal from Sumitovant Biopharma Ltd. and Sumitomo Pharma Co., Ltd. to acquire the remaining shares of…
Read More...